T32 CA236734/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	2
2021	8
2022	4
2023	2
2024	0

1

Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?

Lentz RW, Colton MD, Mitra SS, Messersmith WA. Lentz RW, et al. Mol Cancer Ther. 2021 Jun;20(6):961-974. doi: 10.1158/1535-7163.MCT-21-0041. Epub 2021 Apr 13. Mol Cancer Ther. 2021. PMID: 33850005 Free PMC article. Review.

2

Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.

Lentz RW, Messersmith WA. Lentz RW, et al. J Clin Oncol. 2021 Dec 10;39(35):3887-3889. doi: 10.1200/JCO.21.01993. Epub 2021 Sep 20. J Clin Oncol. 2021. PMID: 34541862 No abstract available.

3

Top advances of the year: Leukemia.

Kent A, Pollyea DA. Kent A, et al. Cancer. 2023 Apr 1;129(7):981-985. doi: 10.1002/cncr.34619. Epub 2022 Dec 30. Cancer. 2023. PMID: 36585394 Free PMC article.

4

Chimeric non-antigen receptors in T cell-based cancer therapy.

Guo J, Kent A, Davila E. Guo J, et al. J Immunother Cancer. 2021 Aug;9(8):e002628. doi: 10.1136/jitc-2021-002628. J Immunother Cancer. 2021. PMID: 34344725 Free PMC article. Review.

5

Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.

Kagihara JA, Shagisultanova E, Afghahi A, Diamond JR. Kagihara JA, et al. Curr Breast Cancer Rep. 2021 Sep;13(3):216-226. doi: 10.1007/s12609-021-00416-0. Epub 2021 May 4. Curr Breast Cancer Rep. 2021. PMID: 34457184 Free PMC article.

6

Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products.

Murphy LA, Marians RC, Miller K, Brenton MD, Mallo RLV, Kohler ME, Fry TJ, Winters AC. Murphy LA, et al. Cytotherapy. 2023 Jan;25(1):94-102. doi: 10.1016/j.jcyt.2022.09.004. Epub 2022 Oct 14. Cytotherapy. 2023. PMID: 36253252 Free PMC article.

7

Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions.

Kagihara JA, Andress M, Diamond JR. Kagihara JA, et al. Expert Rev Precis Med Drug Dev. 2020;5(2):59-65. doi: 10.1080/23808993.2020.1730694. Epub 2020 Feb 20. Expert Rev Precis Med Drug Dev. 2020. PMID: 32190733 Free PMC article.

8

Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.

Chua CC, Hammond D, Kent A, Tiong IS, Konopleva MY, Pollyea DA, DiNardo CD, Wei AH. Chua CC, et al. Blood Adv. 2022 Jul 12;6(13):3879-3883. doi: 10.1182/bloodadvances.2022007083. Blood Adv. 2022. PMID: 35511730 Free PMC article.

9

Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study.

Schreiber AR, Kagihara J, Eguchi M, Kabos P, Fisher CM, Meyer E, Molina E, Kondapalli L, Bradley CJ, Diamond JR. Schreiber AR, et al. Breast Cancer Res Treat. 2022 Jan;191(2):389-399. doi: 10.1007/s10549-021-06424-z. Epub 2021 Oct 27. Breast Cancer Res Treat. 2022. PMID: 34705147 Free PMC article.

10

Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Shay RC, Diamond JR, Kagihara JA, Sams SB. Shay RC, et al. J Breast Cancer. 2021 Feb;24(1):106-116. doi: 10.4048/jbc.2021.24.e2. J Breast Cancer. 2021. PMID: 33634625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year